TRICORT 40MGML INJECTION

Land: Malaysia

Sprog: engelsk

Kilde: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Køb det nu

Produktets egenskaber Produktets egenskaber (SPC)
17-03-2023

Aktiv bestanddel:

TRIAMCINOLONE ACETONIDE

Tilgængelig fra:

PAHANG PHARMACY SDN. BHD.

INN (International Name):

TRIAMCINOLONE ACETONIDE

Enheder i pakken:

1 Vials

Fremstillet af:

CADILA PHARM LTD

Produktets egenskaber

                                BACK SIDE
Pheochromocytoma crisis, which may be fatal, has been reported after
administration of systemic corticosteroids. Corticosteroids
should only be administered to patients with suspected or identified
pheochromocytoma after an appropriate risk/benefit evaluation.
OXXXXXXX
1389, Trasad Road, Dholka-382225,
Dist: Ahmedabad, Gujarat State, India. DATE OF REVISION:
15th March 2023
CO-TREATMENT WITH CYP3A INHIBITORS,
including cobicistat-containing products, is expected to increase the
risk of systemic side-
effects. The combination should be avoided unless the benefit
outweighs the increased risk of systemic corticosteroid side-effects,
in
which case patients should be monitored for systemic corticosteroid
side-effects.
Size : 120 x 400 mm
Export : Malaysia
Pantone P Black C
DG-15/03/23-V06
DG-18/11/22-V05
DG-28/07/22-V04
DG-21/07/22-V03
SS-29/11/18-V02
HV-10/10/16-V01
                                
                                Læs hele dokumentet
                                
                            

Søg underretninger relateret til dette produkt